Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

SELL
$56.06 - $74.11 $269,088 - $355,728
-4,800 Closed
0 $0
Q4 2021

Feb 03, 2022

SELL
$60.19 - $97.37 $475,501 - $769,223
-7,900 Reduced 62.2%
4,800 $359,000
Q3 2021

Oct 21, 2021

SELL
$41.02 - $58.65 $471,730 - $674,475
-11,500 Reduced 47.52%
12,700 $721,000
Q2 2021

Aug 13, 2021

BUY
$43.76 - $53.11 $4,376 - $5,311
100 Added 0.41%
24,200 $1.07 Million
Q1 2021

Apr 30, 2021

BUY
$41.69 - $54.95 $250,140 - $329,700
6,000 Added 33.15%
24,100 $1.19 Million
Q4 2020

Feb 16, 2021

BUY
$41.16 - $47.47 $135,828 - $156,651
3,300 Added 22.3%
18,100 $762,000
Q3 2020

Nov 12, 2020

BUY
$43.36 - $53.53 $65,040 - $80,295
1,500 Added 11.28%
14,800 $678,000
Q2 2020

Aug 12, 2020

BUY
$46.37 - $57.58 $60,281 - $74,854
1,300 Added 10.83%
13,300 $668,000
Q1 2020

May 12, 2020

SELL
$40.22 - $62.0 $32,176 - $49,600
-800 Reduced 6.25%
12,000 $617,000
Q4 2019

Jan 27, 2020

BUY
$57.95 - $66.61 $127,490 - $146,542
2,200 Added 20.75%
12,800 $791,000
Q3 2019

Oct 22, 2019

BUY
$60.08 - $88.17 $42,056 - $61,719
700 Added 7.07%
10,600 $637,000
Q2 2019

Jul 26, 2019

BUY
$81.3 - $97.35 $40,650 - $48,675
500 Added 5.32%
9,900 $835,000
Q1 2019

Apr 25, 2019

SELL
$69.08 - $105.66 $110,528 - $169,056
-1,600 Reduced 14.55%
9,400 $898,000
Q4 2018

Feb 07, 2019

BUY
$65.41 - $84.65 $78,492 - $101,580
1,200 Added 12.24%
11,000 $779,000
Q3 2018

Nov 02, 2018

BUY
$85.46 - $126.37 $837,507 - $1.24 Million
9,800 New
9,800 $838,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $198M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.